Resmed Inc. buy KeyCorp
Start price
26.04.24
/
50%
€190.40
Target price
26.04.25
€222.05
Performance (%)
10.61%
End price
27.04.25
€210.60
Summary
This prediction ended on 27.04.25 with a price of €210.60. The BUY prediction by KeyCorp finished with a performance of 10.61%. KeyCorp has a follow-up prediction for Resmed Inc. where he still thinks Resmed Inc. is a Buy. Dividends of €1.93 are taken into consideration when calculating the performance. KeyCorp has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Resmed Inc. | -1.818% | -1.818% | -7.613% |
| iShares Core DAX® | 0.396% | -0.010% | 17.421% |
| iShares Nasdaq 100 | 0.881% | -0.819% | 7.914% |
| iShares Nikkei 225® | 1.405% | -3.232% | 12.470% |
| iShares S&P 500 | 0.259% | -0.051% | 2.814% |
Comments by KeyCorp for this prediction
In the thread Resmed Inc. diskutieren
ResMed Inc. (NYSE: RMD) had its price target raised by analysts at KeyCorp from $227.00 to $238.00. They now have an "overweight" rating on the stock.
Ratings data for RMD provided by MarketBeat
In the thread Trading Resmed Inc.
Die von KeyCorp gewählte maximale Laufzeit wurde überschritten